DNp63, the N-terminal truncated isoform of p63, has been found to be overexpressed in several human epithelial cancers, including nasopharyngeal carcinomas (NPCs), suggesting a function in carcinogenesis. Trans-resveratrol (RSV) has been shown to exert proapoptotic activities through a p53-dependent or p53-independent pathway in various cancer cells. However, the effects of RSV on NPC are still unexplored. In this study, we investigated the apoptotic effects of RSV on DNp63-overexpressing NPC cell lines. We showed that RSV (12-100 mM) induced dose-dependent growth suppression, cell-cycle arrest in the S phase and caspasedependent apoptosis in NPC-TW076 and NPC-TW039 cells. The RSV effect was accompanied by the downregulation of DNp63 and the upregulation of p53 protein in a dose-dependent manner. By using small-interfering RNA (siRNA) technology, we found that the targeted silencing of DNp63 induced apoptosis and sensitized the NPC cells to RSV-induced apoptosis through caspase-3 activation, whereas suppression of p53 by siRNA did not inhibit RSV-induced apoptosis. Furthermore, transfection with p53 siRNA or pretreatment with caspase inhibitors (Z-VAD-fmk or Z-DEVD-fmk) had no influence on the RSV downregulation of DNp63. Interestingly, ecoptic expression of DNp63 did not significantly block RSV-induced cell death and was also downregulated after RSV treatment. Downregulation of DNp63 by RSV was shown to occur at the mRNA transcript and post-translational levels. Importantly, RSV enhanced chemotheraptic drug-induced apoptosis in NPC and two human carcinoma cell lines, HT1376 and Hep3B cells. These results suggested that DNp63, but not p53, is a molecular target of RSV-induced apoptosis and the regulation of DNp63 expression by RSV may provide a therapeutic effect of RSV in human NPC.
Introduction
Nasopharyngeal carcinoma (NPC) is a high-incidence malignancy in Southern China, Southeast Asia, and Northern Africa. The epidemiologic evidence implies that both environmental factors and genetic susceptibility have roles in the development of NPC. Genetic alternations involving tumor suppressor genes and proto-oncogenes in multiple cellular pathways are believed to be important in the stages of NPC carcinogenesis. Mutation of the p53 gene has been detected in 450% of human tumors, but it is rare in NPC. 1 In contrast, DNp63 is overexpressed in up to 90% of NPC cases and contributes to the pathogenesis of NPC. [1] [2] [3] It also has important functions in the regulation of cell-cycle progression and maintenance of the tumor cell phenotype in NPC cells. 4 Recent studies showed the p63 protein, a homolog of the p53 tumor suppressor, had important function in embryonic epithelial development, tumorigenesis and tumor response to therapy. 5 Owing to alternative promoter usage, the p63 gene generates two major types of protein isoforms, TAp63 and DNp63. TAp63 resembles p53 in many ways, including the ability to transactivate p53-target genes and induces apoptosis when overexpressed. 6, 7 DNp63 lacks the N-terminal transactivation domain and is thought to antagonize TAp63 and p53 in targeting gene regulation. 6, 8, 9 DNp63 has been shown to be the predominant form of p63 expressed in squamous cell carcinomas. 10 Overexpression of a DNp63 isoform in Rat-1A cells increases colony growth in soft agar and xenograft tumor formation in nude mice, suggesting an oncogenic function. 11 It has also been hypothesized that DNp63 contributes to tumorigenesis based on its ability to inhibit p53-dependent transactivation in vitro after its ectopic expression. 12, 13 In addition, DNp63 has been shown to exhibit an antiapoptotic effect through the dominant-negative effect of binding to promoters of the p53-target genes. 12 Trans-resveratrol (RSV), a natural antioxidant and phytoalexin, is widely distributed in grapes, fruits and the root tubers of Polygonum cuspidatum. 14, 15 It has been used as an important constituent in Chinese and Japanese folk medicine. There are a growing number of reports showing that RSV can prevent or slow the progression of a wide variety of illnesses, including cancers, 16 cardiovascular disease 17 and ischemia reperfusion injuries 14, 18 as well as enhance stress resistance 19 and extend the life spans of various organisms. 20, 21 RSV has been shown to interfere in the pathways of cell apoptosis by the direct triggering of the proapoptotic signaling cascades 22 and/or by blocking antiapoptotic molecules. 23 However, the anticarcinogenetic effect of RSV in the regulation of DNp63 has not been elucidated.
In this study, we showed that RSV induced apoptosis in NPC-TW076 and NPC-TW039 cells. In contrast to p53, DNp63 is downregulated after treatment with RSV. Using RNA interference, we investigated the effects and mechanisms of silencing DNp63 or p53 in RSV-treated cells. We found that the downregulation of DNp63 that results in caspase activation is critical for RSV-induced apoptosis. Furthermore, suppression of DNp63 expression by small-interfering RNA (siRNA) sensitized NPC cells to RSV-induced apoptosis. In addition, the mechanisms of RSV-induced downregulation of DNp63 and the anticancer drug-induced apoptosis in human cancer cell lines were also investigated.
Materials and methods

Cell culture and reagents
Human NPC cell lines NPC-TW076 and NPC-TW039 were isolated from keratinized nasopharyngeal squamous cell carcinoma. 24 NPC cells, HT1376 human bladder carcinoma cell and Hep3B human hepatocarcinoma cell were maintained in basal medium (DMEM/F-12 at 1:1 v/v; Invitrogen, Carlsbad, CA) supplemented with 5-10% fetal bovine serum in a humidified incubator at 37 1C under 5% CO 2 /95% air. The caspase inhibitors Z-VAD-fmk and Z-DEVD-fmk, the anticancer drugs 5-FU and cisplatinum, doxorubicin and cyclohexmide (CHX) were purchased from Sigma Chemical (St Louis, MO).
Cell proliferation assays
Cell proliferation was determined by the colorimetric MTS assay using the CellTiter 96 AQueous One Solution Proliferation Assay System from Promega (Madison, WI). Briefly, 2 Â 10 4 cells per well were plated in 96-well plates and incubated overnight. The cells were then treated with RSV at concentrations ranging from 5 to 100 mM for 24 h. MTS solution was added; during the assay, MTS is converted into a soluble formazan product. After incubation for 1-4 h at 37 1C, the absorbance, which is directly proportional to the number of viable cells in the cultures, was measured at 490 nm using a microplate reader.
Cell-cycle distribution analysis Propidium iodide (PI) staining was used to analyze the DNA content. Cells were plated in 35-mm dishes at concentrations determined to yield 60-70% confluence within 24 h. Cells were then treated with RSV (10-100 mM) for 24 h. Both the adherent and floating cells were harvested, and the cells were resuspended in PBS, fixed with 70% ethanol, labeled with PI (0.05 mg ml -1 ) and incubated at room temperature in the dark for 30 min. DNA content was then analyzed using an FACScan instrument equipped with FACStation running cell Quest software (Becton Dickinson, San Jose, CA).
Apoptosis assay
Cell apoptosis was assayed by Annexin V-Cy5 and PI staining (BioVision, Mountain View, CA) followed by FACS analysis. The cells were treated with RSV, 5-FU or cisplatin at the indicated concentrations for 24 h. The cells were pelleted and resuspended in Annexin V-binding buffer (10 mM HEPES, 150 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 , pH 7.4) containing Annexin V-Cy5 (1:1000) and 1 mg ml -1 PI. After incubation at room temperature for 5 min, the cells were analyzed with an FACSCalibur flow cytometer (Becton Dickinson). The percentage of total apoptotic events was defined as the sum of the cells in the early stage (Annexin V-Cy5 positive/PI negative) or late stage (Annexin V-Cy5 positive/PI positive) of apoptosis as previously described. 4 Preparation of cell lysates and western blot analysis The cells were seeded at a 1 Â 10 6 per 100-mm culture dish. The cells were incubated for 24 h and were treated with RSV at the desired concentrations. Eighteen hours after treatment, the cells were washed with ice-cold phosphate-buffered saline and lysed in Mammalian Protein Extraction Reagent (Pierce Chemical, Rockford, IL). Protein samples (20 mg per lane) were separated on a 10% sodium dodecyl sulfate (SDS)-polyacrylamide gel and blotted onto polyvinylidene difluoride membranes (Immobilon(TM)-P, Millipore, Bedford, MA), blocked in TTBS and probed with primary antibodies (1:1000 for p63 and poly-(ADP-ribose) polymerase (PARP) and 1:10000 for glyceraldehyde 3-phosphate dehydrogenase (GAPDH)) overnight at 4 1C. The membranes were then incubated with the appropriate horseradish peroxidaseconjugated secondary antibodies (1:2000 0 . The p53 siRNA was purchased from Cell Signaling Technology (5 0 -CUACUUCCUGAAAAC AACGTT). The transfection was performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. The effectiveness of siRNA silencing was assayed by western blot analysis using anti-DNp63 or anti-p53 antibody.
Infection of recombinant adenovirus vectors
For overexpression of DNp63, semi-confluent cultures of NPC cells in six-well cell culture dishes were infected with the desired recombinant adenovirus vectors. The adenovirus vector, designated Ad-DNp63, was constructed as described before. 25 A recombinant adenovirus carrying only GFP was used as a control. Briefly, viral stock was diluted into 0.5 ml culture medium and added to the culture dishes. The infection reactions were incubated for 2 h, and 1.5 ml of culture medium was then added per culture dish. Then, the cell lysates were analyzed for the expression of DNp63 by immunoblotting. After confirming the overexpression of DNp63, the Ad-DNp63-transfected cells were treated with or without RSV for another 24 h and cell viability was assayed by MTS assay.
Semi-quantitative PCR
A range of PCR reaction cycles (25, 27, 30, 33, 36, 39 and 40 cycles) were performed to evaluate the relative abundance of p63 transcripts. Diluted cDNA (1:4; 12.5 ng/50 ml PCR reaction) undergoing 25 and 30 PCR cycles was observed to be within the logarithmic phase of amplification and yielded reproducible results with the primers used. For isoform-specific quantitation of DNp63, the primers used were DNp63-1 sense, 5
0 -TGC CCAGACTCAATTTAGTGAG-3 0 and p63-2 antisense, 5 0 -TCTGGATGGGGCATGTCTTTGC-3 0 . PCR was performed for 25-30 cycles at 95 1C for 1 min, 60 1C for 0.5 min and 72 1C for 1 min in 1.5 mM MgCl 2 containing reaction buffer (PCR buffer II; Perkin-Elmer, Norwalk, CT). A total of 10 ml of RT-PCR products were resolved on 1.2% agarose gels. Quantization of expression levels was achieved by densitometric scanning of the ethidium bromide-stained gels. Absolute area integrations of the curves representing each specimen were normalized to that of GAPDH.
Statistical analyses
Data are presented as means ± s.e.m. The statistical differences were determined using Student-NewmanKeuls' Test and Dunn's Test (Sigma Stat Software Program, Jandel Scientific, San Rafael, CA). A P-value of p0.05 was considered as significant.
Results
RSV-induced growth suppression and cell-cycle arrest in NPC cells
RSV has been shown to suppress the proliferation of several cancer cell lines and in vivo cancer models. 14, 26 To determine the effect of RSV on the growth of NPC cells, NPC-TW076 and NPC-TW039 cells were treated with RSV at concentrations ranging from 12 to 100 mM for 24 h and cell growth determined by the MTS assay. Incubation of cells with RSV resulted in dose-dependent growth suppression ( Figure 1a ). Next, cell-cycle distributions were analyzed by flow cytometry to determine whether the growth suppression of NPC cells was associated with a disturbance in cell-cycle regulation. The cells were analyzed after RSV (100 mM) treatment for 24 h. RSV treatment inhibited cell-cycle progression at the S phase by 24.22 and 18.85% and increased the sub-G1 phase by 11.41 and 10.9% in NPC-TW076 and NPC-TW039 cells, respectively ( Figure 1b ).
RSV-induced cell apoptosis
The induction of apoptosis of NPC cells was further investigated by the binding of Annexin V-Cy5 to NPC-TW076 and NPC-TW039 cells treated with RSV. As shown in Figure 2a , the percentage of Annexin V-Cy5-binding NPC cells markedly increased after treatment with RSV at concentrations of 50 and 100 mM for 24 h (NPC-TW076, 22 and 32%; NPC-TW039, 19 and 27%, respectively). In another measure to confirm the induction of apoptosis, we evaluated the cleavage of PARP in cells treated with RSV for 24 h by western blotting. Figure 2b clearly shows the dose-dependent cleavage of PARP by RSV (50-100 mM) in both cell lines. Taken together, these results indicate that the antiproliferative effect of RSV was associated with the inhibition cell-cycle progression at the S phase and the induction of cell apoptosis.
We next examined whether the caspase cascade is involved in RSV-induced apoptosis. NPC-TW076 cells were treated with the pan-caspase inhibitor Z-VAD-fmk (50 mM) or a specific caspase-3 inhibitor Z-DEVD-fmk (50 mM) for 2 h before treatment with RSV (100 mM) for 24 h. The cells were then subjected to Annexin V-Cy5/PI labeling and FACS analysis or western blotting assay. As shown in Figure 2c , the RSV-enhanced Annexin V-positive cell population was dramatically reduced with either Z-VAD-fmk or Z-DEVD-fmk treatment. Importantly, Z-VAD-fmk and Z-DEVD-fmk severely inhibited RSV-induced PARP cleavage, indicating the involvement of caspase activity.
DNp63 is a target of RSV in NPC cells
DNp63 has been shown to exhibit an antiapoptotic effect through a dominant-negative effect of binding to promoters of the p53-target genes. 12 We, therefore, investigated whether the induction of apoptosis in NPC cells by RSV would lead to changes in the levels of DNp63 and p53 expression in NPC cells. NPC cells were treated with RSV (12-100 mM) for 24 h and the cell lysate was analyzed for DNp63 and p53 expression by western blotting. As shown in Figure 3 , the expression level of DNp63 was significantly downregulated by RSV treatment in a dose-dependent manner. Interestingly, the suppression of DNp63 expression by RSV was accompanied by a dosedependent increased expression and phosphorylation of p53 (p-p53) at Ser15 (Figure 3 ).
Inhibition of p53 does not prevent RSV-induced apoptosis
DNp63 has been shown to have an antiapoptotic function, irrespective of the p53 expression status. 27, 28 However, the function of p53 in NPC cells in which RSV treatment upregulates p53 needs to be investigated. To analyze the functions of the p53 upregulation involved in cell apoptosis and DNp63 degradation, NPC-TW076 cell was transfected with p53 siRNA for 48 h before RSV treatment (50-100 mM) for 24 h. The cells were then subjected to Annexin V-Cy5/PI labeling and FACS analysis or western blotting assay. As shown in Figure 4a , the cell apoptosis induced by RSV was unchanged after transfection with control siRNA. However, despite the reduction in p53 expression induced by siRNA, RSV still retained its ability to induce apoptosis. Further study showed that the targeted inhibition of p53 with siRNA effectively reduced the expression of p53, but did not interfere with the downregulation of DNp63 induced by RSV (Figure 4b) . However, the induction of PARP and caspase-3 cleavages were increased in NPC cells under these conditions. Remarkably, the 17-kDa active caspase-3 induced by RSV increased approximately 4.7-and 17-fold in cells transfected with 20 and 60 nM p53 siRNA, respectively (Figure 4c ). These results indicated that RSV induced the apoptotic program through a mechanism other than upregulation of the p53 protein.
The function of caspase-3 in the downregulation of DNp63 The ectopic expression of p53 was shown to mediate DNp63 degradation through a caspase-activation pathway. 29, 30 To assess the function of the caspase pathway in NPC cells in which RSV treatment activated caspase-3, NPC-TW076 cells were pretreated with caspase inhibitors (Z-VAD-fmk or Z-DEVD-fmk) for 2 h before exposure with 100 mM RSV for 24 h. The cell lysates were then subjected to western blotting. Figure 5 showed that pretreatment with Z-VAD-fmk or Z-DEVD-fmk did not block the degradation of DNp63 protein in response to RSV, although these inhibitors increased the expression of DNp63 protein in control groups without RSV treatment. The result shows that the downregulation of DNp63 protein in response to RSV in these NPC cells is not mediated through the p53/caspase pathway. Knockdown of DNp63 with siRNA sensitizes NPC cells to RSV In order to independently validate the specificity of the DNp63 protein in RSV-induced apoptosis, the apoptotic effect of DNp63 knockdown was determined. NPC-TW076 cells were transfected with DNp63 siRNA (20 and 60 nM) or control siRNA for 48 h before RSV treatment (100 mM). As shown in Figure 6a , a dose-dependent reduction of DNp63 expression was observed in cells transfected with DNp63 siRNA. Moreover, siRNAmediated apoptosis was shown by the induction of active caspase-3 and cleaved PARP proteins. The levels of the 17-kDa active caspase-3 after transfection with 20 nM and 60 nM siRNA, which are represented in the graph, increased 2.5-and 3-fold (Figure 6b ). Remarkably, transfection with DNp63 siRNA markedly increased the susceptibility to RSV-induced apoptosis. This effect was shown by significantly reducing the expression of DNp63 and increasing the active caspase-3 and cleaved PARP proteins. Apoptosis was further evaluated by flow cytometry of Annexin V-stained cells. Consistently, RSV-induced apoptosis was not affected by control siRNA transfection, but was significantly increased by DNp63 siRNA at a concentration of 60 nM, suggesting that DNp63 siRNA increased the sensitization effect of RSV on cell apoptosis (Figure 6c ).
Exogenous expression of DNp63 was also downregulated by RSV To see whether transfected DNp63 blocked the RSVinduced cell death, NPC cells were infected with Ad-DNp63 or Ad-Ctrl for 24 h and the levels of exogenously expressed DNp63 were monitored by western blot. As shown in Figure 7a , ectopically expressed DNp63 showed a higher molecular mass as they expressed the v5-tag in their N-terminal. After confirming the presence of exogenous DNp63, the infected cell was treated with or without RSV for 24 h and the cell viability was examined by MTS assay (Figure 7b ). Exogenous expression of DNp63 did not significantly influence the cell viability, suggesting that high level of endogenous DNp63 is sufficient to maintain cell survival. However, introduction of DNp63 did not significantly block the RSV-induced cell death. Interestingly, in addition to endogenous DNp63, exogenous DNp63 protein was remarkably downregulated in cells infected with Ad-DNp63 after exposure to RSV at concentration of 100 mM (Figure 7c ). The apoptotic effect was shown by cleaved PARP that showed that the degrading exogenous DNp63 protein could not protect cells from RSV-induced damage in the Ad-DNp63-transfected cells. This result might partially explain the lack of effect of the ectopically expressed DNp63 in blocking RSV-induced cell death. Taken together, the data in Figures 6 and 7 indicate that the downregulation of DNp63 is required for RSV-induced cell apoptosis in NPC cells.
Decreased DNp63 protein in the transcript and post-translational levels To verify the possible mechanism of RSV-induced downregulation of DNp63, we examined whether the reduced DNp63 protein is due to a reduced DNp63 mRNA level that quantified by semi-quantitative RT-PCR. As shown in Figure 8a , treatment of the cell with RSV resulted in a dose-dependent reduction of DNp63 transcript. To further characterize whether DNp63 was regulated at the level of protein stability, NPC cells were treated with CHX or MG132 in combination with or without RSV for 2, 6 and 12 h. As shown in Figure 8b alone caused a time-dependent increase in DNp63 protein levels, indicating that under normal growth conditions, DNp63 protein is degraded in a proteasome-dependent manner. Addition of MG132 to NPC cells did not prevent the decrease of DNp63 protein after treatment with RSV for 12 h. This result showed that downregulation of DNp63 was proteasome independent (Figure 8b , lower panel).
RSV enhanced the susceptibility of drug-induced apoptosis RSV has been shown as a chemosensitizer in human cancer cells (Fulda and Debatin, 2004) . 27 Given the restricted pattern of DNp63 protein expression in select tissues in vivo, in particular carcinoma, we further focused our studies on the potential of RSV on drug-treated NPC cells and two DNp63-expressed cells, HT1376, a human bladder cancer cell, 31 as well as Hep3B, a human hepatocarcinoma cell. 32 As shown in Figure 9a , RSV remarkably enhanced the effect of 5-FU-, cisplatinum-or doxorubicin-induced apoptosis in NPC cells. Treatment with RSV resulted in downregulation of DNp63 protein in HT1376 and Hep3B cells (Figure 9b ) and enhanced the sensitization of cells to drug-induced apoptosis. These results indicated that RSV enhanced the proapoptotic effects of chemotherapeutic drugs in human carcinoma cells. 
Discussion
The chemopreventive activity of RSV is largely based on its proapoptotic effects that act in a p53-dependent or p53-independent manner. In this study, we investigated the conditional regulation of apoptosis induced by RSV in DNp63-expressing NPC cells and found that the RSV-induced downregulation of DNp63 resulted in caspase-dependent apoptosis. The results showed that RSV induces dose-dependent growth inhibition and cell apoptosis because of the induction of S-phase arrest, caspase-3 activation and PARP cleavage. This RSV effect was accompanied by the upregulation of p53 and downregulation of DNp63 protein levels. However, we found that DNp63, but not p53, was correlated with RSVinduced cell apoptosis. In addition, the upregulation of p53 or caspase activation did not involve in degradation of the DNp63 protein. Importantly, sensitization to RSV was also found in DNp63-expressing NPC cells after the suppression of DNp63 expression by siRNA. RSVmediated downregulation of DNp63 expression was found to mediate through reduction of the mRNA transcript and at least in part at the level of protein stability. Thus, the potential combination of RSV with DNp63 siRNA could be exploited for cancer therapy to render tumor cells more susceptible to cell death induction.
RSV has been shown to induce apoptosis in various cancer cell lines. 33 The different dose ranges of RSV used to induce cellular changes, such as growth inhibition, cell-cycle arrest and apoptosis have been extensively investigated. 33 This study showed that treatment with 10-100 mM RSV arrests the cell cycle of NPC cells in the S phase, whereas concentrations in the 50-100 mM range were required to induce cell apoptosis. The S-phase arrest observed upon treatment with RSV has been explained by the inhibition of ribonucleotide reductase or DNA polymerase. 34 However, we also showed that RSV enhances the proapoptotic effects of chemotherapeutic drugs such as 5-FU, cisplatium and doxirubicin in DNp63-expressed cancer cells. Thus, the potential of RSV as a chemosensitizer can be exploited for cancer therapy to render NPC cancer cells more susceptible to cell death induction by anticancer drugs.
27
DNp63 has been shown to be highly expressed in NPC and interacts with the Epstein-Barr virus nuclear antigen 5 (EBNA-5) associated with the differential stage in the pathogenesis of NPC. 1, 35, 36 The expression of DNp63 alone is able to drive clonal proliferation in primary nasopharyngeal cells in culture, whereas the downregulation of DNp63 induced cellular apoptosis. 4, 36 In addition, DNp63 is downregulated in response to UV-B irradiation, 37 suggesting its function in a stressful condition. We observed that the downregulation of DNp63 by RSV correlates with the induction of apoptosis through activation of caspase-3. This conclusion was drawn from the observations that the targeted suppression of DNp63 or p53 by siRNA after RSV treatment resulted in caspase-3-activated apoptosis. Interestingly, exogenous expression of DNp63 protein was also downregulated by RSV. Furthermore, the combination of RSV with DNp63 siRNA enhanced the triggering of apoptosis. It is reported that RSV's potential in anticancer therapy may largely reside in its ability to sensitize tumor cells for death induction. 27 Importantly, we identified the chemopreventive compound RSV as a novel therapeutic to target DNp63 expression in NPC cells, and some DNp63-expressed cancer cells. This study supports a function for DNp63 in cellular survival and apoptosis, which facilitates the pathogenesis of NPC.
An early study showed the activation of p53 in response to RSV-induced cell apoptosis. 28 However, RSV has been shown to induce apoptosis by p53-independent mechanisms in several human cancers. 15, 26, 27, 38 It is important to note that this study shows that RSV's apoptotic effect is independent of p53 even though the level of p53 is upregulated. It is uncertain whether this represents a marker for cell-cycle arrest or cytoprotection. Nevertheless, the protection of cells from death after anticancer treatment by p53 has been documented in many different cell types. 39 This limited protective effect may be the result of p53 exerting its checkpoint function. 39 Our study shows that the downregulation of DNp63 in response to RSV under conditions of p53 silencing is still sufficient to induce the apoptotic effect. Given that most cancers are defective in p53 itself or in p53-dependent pathways, 40 this p53-independent apoptosis confers an advantage to the use of RSV as an anticancer drug.
DNp63 is a positive and negative transcriptional target of p53 and DNp63, respectively. 31, 29, 41 The presence of a p53-binding site has been reported in the DNp63 promoter region, suggesting that p53 may regulate the transcriptional activity of the DNp63 gene. 41 In addition, ectopic expression of p53 is shown to result in the caspasedependent degradation of DNp63 protein. 29 It has been shown that p63 is a target of caspases, leading to cell apoptosis. 30 Our study shows that the downregulation of DNp63 in response to RSV can occur independently of p53 or caspases in NPC cell lines. We also showed that in response to UV-B or cisplatin, DNp63 is recruited to the binding element within the DNp63 promoter and has an important function in negative autoregulation. 41 In human NPC-TW076 cells, DNp63 exerts its negative function on the regulation of the cellular levels of DNp63 protein through binding to the p53-binding element. 31 Thus, it will be of particular interest to determine whether this mechanism contributes to the RSV-induced downregulation of DNp63.
Reactive oxygen species (ROS) have been shown to have a function in the initiation and progression of cancer through directly damaging DNA and other macromolecules. 42, 43 In addition to its possible modulation of antioxidant enzymes involved in the Phase II response, RSV has an intrinsic antioxidant capacity that could be related to its chemopreventive effects. 26 In vivo, RSV has been shown to increase plasma antioxidant capacity and decrease lipid peroxidation. 26 It has been clearly shown that the antioxidant effect of RSV is not merely because of its free radical scavenging, but mediates through influence of the nicotinamide adenine dinucleotide phosphate-oxidase complex assembly in the membrane. 19 Recently, DNp63 is shown to serve as a pro-survival factor by upregulating glutathione peroxidase to inhibit oxidative stress-induced apoptosis. 44 However, it is not clear whether the antioxidant activity of RSV is associated with the downregulation of DNp63. Further efforts are necessary to continue investigation on the biochemical functions of RSV, which related to
